USD 500 mln 8% non-cumulative subordinated notes


 
TIDMAGN 
 
AEGON announces offering of USD 500 million of 8.00% non-cumulative 
subordinated notes due 2042 
 
AEGON announces the pricing of an offering of USD 500 million of 8.00% 
non-cumulative subordinated notes due 2042 in an underwritten public offering 
in the United States registered with the U.S. Securities Exchange Commission 
(SEC). 
 
As part of the offering, AEGON has granted the underwriters a 30-day option to 
purchase up to an additional USD 75 million of notes to cover over-allotments. 
If this option is exercised in full, the gross proceeds of the offering will be 
USD 575 million. 
 
The notes will bear interest at a fixed rate of 8% and will not be cumulative 
and are priced at 100% of their principal amount. The coupon may be cancelled 
under certain circumstances. The notes will be issued in denominations of USD 
25. Application will be made to list the notes on the New York Stock Exchange 
(NYSE). The offering is expected to be settled on January 31, 2012 and the 
notes are expected to be admitted for trading on the NYSE within 30 days 
thereafter. The proceeds from the issuance of the notes will be used for 
general corporate purposes. 
 
The joint book-runners for the offering of the notes are BofA Merrill Lynch, 
Citigroup, Morgan Stanley and Wells Fargo Securities. A prospectus may be 
obtained from BofA Merrill Lynch at 4 World Financial Center, New York, NY 
10080, Attention: Prospectus Department or e-mail: 
dg.prospectus_requests@baml.com. A prospectus may also be obtained for free by 
visiting the SEC website at www.sec.gov. 
 
 
 
About AEGON 
 
As an international life insurance, pension and asset management company based 
in The Hague, AEGON has businesses in over twenty markets in the Americas, 
Europe and Asia. AEGON companies employ approximately 26,000 people and have 
some 40 million customers across the globe. 
 
Contact information 
 
Media relations: Greg Tucker, +31(0)70 344 8956, gcc-ir@aegon.com 
 
Investor relations: Willem van den Berg, +31 (0)70 344 8305, 877 548 9668 - toll free USA only, 
ir@aegon.com 
 
Website: www.aegon.com 
 
Forward-looking statements 
 
The statements contained in this press release that are not historical facts 
are forward-looking statements as defined in the US Private Securities 
Litigation Reform Act of 1995. The following are words that identify such 
forward-looking statements: aim, believe, estimate, target, intend, may, 
expect, anticipate, predict, project, counting on, plan, continue, want, 
forecast, goal, should, would, is confident, will, and similar expressions as 
they relate to our company. These statements are not guarantees of future 
performance and involve risks, uncertainties and assumptions that are difficult 
to predict. We undertake no obligation to publicly update or revise any 
forward-looking statements. Readers are cautioned not to place undue reliance 
on these forward-looking statements, which merely reflect company expectations 
at the time of writing. Actual results may differ materially from expectations 
conveyed in forward-looking statements due to changes caused by various risks 
and uncertainties. Such risks and uncertainties include but are not limited to 
the following: 
 
  * changes in general economic conditions, particularly in the United States, 
    the Netherlands and the United Kingdom; 
 
  * changes in the performance of financial markets, including emerging 
    markets, such as with regard to: 
 
    - the frequency and severity of defaults by issuers in our fixed income 
    investment portfolios; and 
 
    - the effects of corporate bankruptcies and/or accounting restatements on the 
    financial markets and the resulting decline in the value of equity and debt 
    securities we hold; 
 
  * the frequency and severity of insured loss events; 
 
  * changes affecting mortality, morbidity, persistence and other factors that 
    may impact the profitability of our insurance products; 
 
  * changes affecting interest rate levels and continuing low or rapidly 
    changing interest rate levels; changes affecting currency exchange rates, 
    in particular the EUR/USD and EUR/GBP exchange rates; 
 
  * changes in the availability of, and costs associated with, liquidity 
    sources such as bank and capital markets funding, as well as conditions in 
    the credit markets in general; 
 
  * increasing levels of competition in the United States, the Netherlands, the 
    United Kingdom and emerging markets; 
 
  * changes in laws and regulations, particularly those affecting our 
    operations, the products we sell, and the attractiveness of certain 
    products to our consumers; 
 
  * regulatory changes relating to the insurance industry in the jurisdictions 
    in which we operate; 
 
  * acts of God, acts of terrorism, acts of war and pandemics; 
 
  * changes in the policies of central banks and/or governments; 
 
  * lowering of one or more of our debt ratings issued by recognized rating 
    organizations and the adverse impact such action may have on our ability to 
    raise capital and on our liquidity and financial condition; 
 
  * lowering of one or more of insurer financial strength ratings of our 
    insurance subsidiaries and the adverse impact such action may have on the 
    premium writings, policy retention, profitability of its insurance 
    subsidiaries and liquidity; 
 
  * the effect of the European Union's Solvency II requirements and other 
    regulations in other jurisdictions affecting the capital we are required to 
    maintain; 
 
  * litigation or regulatory action that could require us to pay significant 
    damages or change the way we do business; 
 
  * customer responsiveness to both new products and distribution channels; 
 
  * competitive, legal, regulatory, or tax changes that affect the distribution 
    cost of or demand for our products; 
 
  * the impact of acquisitions and divestitures, restructurings, product 
    withdrawals and other unusual items, including our ability to integrate 
    acquisitions and to obtain the anticipated results and synergies from 
    acquisitions; 
 
  * our failure to achieve anticipated levels of earnings or operational 
    efficiencies as well as other cost saving initiatives. 
 
Further details of potential risks and uncertainties affecting the company are 
described in the company's filings with Euronext Amsterdam and the US 
Securities and Exchange Commission, including the Annual Report on Form 20-F. 
These forward-looking statements speak only as of the date of this press 
release. Except as required by any applicable law or regulation, the company 
expressly disclaims any obligation or undertaking to release publicly any 
updates or revisions to any forward-looking statements contained herein to 
reflect any change in the company's expectations with regard thereto or any 
change in events, conditions or circumstances on which any such statement is 
based. 
 
JANUARY 25, 2012 
 
Press release 
 
 
 
END
Aegon Nv (LSE:AGN)
過去株価チャート
から 11 2024 まで 12 2024